Showing 17,821 - 17,840 results of 152,992 for search '(( a we decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.85s Refine Results
  1. 17821

    Magneto-optical Response of 3<i>d</i>‑Decorated Polyoxomolybdates with ε‑Keggin Structure by I. V. Andreev (1833067)

    Published 2014
    “…A family of virtually isostructural tetra-capped ε-Keggin-type polyoxomolybdate­(V) cluster compounds, [Mo<sub>12</sub><sup>V</sup>O<sub>28</sub>(μ<sup>2</sup>–OH)<sub>10</sub>(μ<sup>3</sup>–OH)<sub>2</sub>­{M<sup>II</sup>(H<sub>2</sub>O)<sub>3</sub>}<sub>4</sub>]·<i>n</i>H<sub>2</sub>O ({M<sub>4</sub><sup>II</sup>Mo<sub>12</sub><sup>V</sup>}, M = Ni, Co), exhibits magnetic-field-dependent optical response in their electronic absorption spectra in the 0–33 T range. …”
  2. 17822
  3. 17823
  4. 17824
  5. 17825
  6. 17826
  7. 17827
  8. 17828
  9. 17829

    Vanadium Oxides on Aluminum Oxide Supports. 3. Metastable κ-Al<sub>2</sub>O<sub>3</sub>(001) Compared to α-Al<sub>2</sub>O<sub>3</sub>(0001) by Tanya K. Todorova (2026051)

    Published 2007
    “…On the α-Al<sub>2</sub>O<sub>3</sub>(0001) surface, the only stable low-coverage VO<i><sub>x</sub></i> species are dimers with V−O<sup>(2)</sup>−Al interface bonds and a defect formation energy of 2.8 eV. …”
  10. 17830

    Bisphenol A Exposure and Asthma Development in School-Age Children: A Longitudinal Study by Kyoung-Nam Kim (1362867)

    Published 2014
    “…</p><p>Objective</p><p>We hypothesized that exposure to bisphenol A in school-age children was associated with wheezing and asthma.…”
  11. 17831
  12. 17832
  13. 17833
  14. 17834
  15. 17835
  16. 17836
  17. 17837
  18. 17838
  19. 17839
  20. 17840

    Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models by Joseph B. Sempa (7861247)

    Published 2019
    “…An increase in cumulative log viral load is associated with a decrease in CD4 count slope (19.6 cells/μL (95% credible interval: 28.26, 10.93)) and a reduction in the odds of achieving a CD4 counts ≥500 cells/μL (0.42 (95% CI: 0.236, 0.730)) during 5 years of therapy. …”